Leadership

BMG’s Management cumulates a comprehensive experience in research, development, manufacturing, regulatory and licensing.

BMG Pharma Marco Mastrodonato 02

MARCO MASTRODONATO

FOUNDER & CEO

Founder and former Chairman of Delife Pharma Srl a specialty dermatology company which was acquired by the Menarini Group in 2015. As a founder and former Executive Director of Sinclair Pharma PLC, listed on London Stock Exchange, Marco headed up the business development, licensing, and product development division of the group for 9 years.
Later, Sinclair acquired Propharma Srl – a company founded by Marco in 2001. He then guided Sinclair from being a branded generics company into the dermatology, oral care company. This was thanks to the invention and regulatory registration of two medical device regulated products with the FDA and EMA. Marco was also the founder and former Board Member of Metrodora Therapeutics Inc, a biotech company focused on systemic inflammation and treatment of anemia.

ROBERTO BIANCHI

FOUNDER & BOARD MEMBER

Roberto started in 1974 with Ellem, a small Italian pharmaceutical company, where he became a shareholder and C.E.O. his experience ended in 1986, when he successfully sold the Company to Farmitalia Carlo Erba, the leading Italian Pharmaceutical Company at the time; owned by the Montedison Group.
In the period 1986-1992. Roberto Bianchi joined Farmitalia Carlo Erba where he was appointed General Manager and then C.E.O. Since 1988 he also became C.O.O. and then C.E.O. for the pharma business of Erbamont, the Holding Company of the Montedison Group, listed at the NYSE. During this period, he also served as Vice Chairman of Farmindustria and as a Board Member of Federchimica. Starting from 1993 Dr. Bianchi decided to come back to the entrepreneurial activity and founded Aquisitio S.r.l., a financial company that, since then, acted as the holding company of most of the new entrepreneurial activities in the healthcare field.

ROBERTO BIANCHI
bmgpharma claudio ali

CLAUDIO ALÌ

CHAIRMAN

More than 25 years of expertise in Financial and Accountant areas in national and multinational contexts as Telecom Italia, Patrimonio del Trentino and Lattebusche; From 2007 till 2018 General Manager in Patrimonio del Trentino S.p.A. company with €1 billion of assets evaluation.

EDOARDO RICHTER

BOARD MEMBER

Edoardo cumulates more than 35 years’ experience in the pharmaceutical field with extensive experience in marketing, business development, M&A and strategic planning and has held several Director Positions within several companies during his career. He has actively collaborated notably with Angelini Italy, Angenerico, Hexan, CSC Pharmaceutical GmbH covering various senior management responsibilities.
He was a board member in several pharma companies in Italy and internationally. Mr. Richter has gained broad experience in business development and was involved in many international negotiations in Japan, US, EU and Asia. Today he is active as a consultant for some pharma companies in the field of strategic planning & licensing as well as entrepreneurial activities in the healthcare field.

bmgpharma edoardo richter
ROBERTA TERPIN

ROBERTA TERPIN

BOARD MEMBER

Senior investment officer in Friulia S.p.A., private equity firm owned by Friuli Venezia Giulia region (Italy). More than 15 years of experience in the financial sector, both in corporate institutions and PE/venture capitals. Board member in different firms with focus on strategic and financial planning.

PAUL PHULL

CHIEF COMMERCIAL OFFICER

Responsible for global commercial operations of the company including business development, marketing, and sales. Focused on developing and implementing the business development & marketing strategy for BMG products and working with global partners to ensure success in individual markets. Over 30 years of senior-level general management, business development, and sales & marketing experience in the medical device, pharmaceutical, and biotechnology industries.

bmgpharma paul phull
ANNALISA CAVALLI

ANNALISA CAVALLI

VP OF OPERATIONS

Responsible for coordinating business development and alliance management activities within the company to ensure the timely launch of products and appropriate implementation of distribution agreements. Additional responsibilities include project management of new product development teams to ensure the timely availability of new products to the business development team. Experienced as a project manager with full responsibility in product development within medical devices including oral care, dermatology, and gynecology.

LUCA STUCCHI

CHIEF SCIENTIFIC OFFICER

Member of the Royal Society of Chemistry and of the International Society for Hyaluronan Sciences – ISHAS, he’s one of the inventors of our Hyluromimethic technology, patented worldwide, that is being implemented in the development of new medical devices. In BMG Pharma he’s responsible for the development of new products, focusing on the characterization and optimization of the new functional ingredients.

bmg pharma luca stucchi
ENRICO VIGANO

ENRICO VIGANÒ

FINANCIAL DIRECTOR

Chartered accountant and auditor with over 22 years of working experience in multinational groups with complex matrix organizations / NYSE and AIM listed companies in different business fields. Specialized in internal control and tax management providing highly qualified expertise in complex business areas.

ADRIANO RIPARI

CONSUMER BU DIRECTOR

Responsible for business development cosmetics consumer products and online sales worldwide. Over 30 years of senior-level experience in general management, focusing on marketing and export sales in perfumery chains, pharmacy and dept. stores.

ADRIANO RIPARI
bmg pharma giulia colombo 02

GIULIA COLOMBO

DIRECTOR MEDICAL AESTHETICS BU

Pharmaceutical marketing and sales professional with 15 years of experience at International and Italian level.
Starting in Fidia Farmaceutici she developed her skills in the regenerative field, covering many sales responsibilities in hyaluronic acid and regenerative medicine markets.
Thanks to her knowledge-base, she supported international marketing campaigns,including the launch of new applications of HA and designed new projects in aesthetic medicine. After further experiences as head of marketing and corporate, respectively in Errekappa and Mastelli, she is now involved in BMG Pharma to design the strategic international launch of the Hyaluromimethic technology.

Menu